PHILADELPHIA - Kellie Ann Jurado, PhD, has joined the Perelman School of Medicine at the University of Pennsylvania as a Presidential Assistant Professor of Microbiology. Jurado’s research examines how the immune system interacts with viral infections. Her current work investigates the abnormal immune response during Zika virus infection, including how the immune system reacts to Zika in the brain.
As a new Penn faculty member, Jurado will continue her research on Zika virus pathogenesis and how antigen-presenting cells shape T cell responses in the central nervous system. She will also start on a new line of inquiry exploring the enterovirus D68, an emerging and important viral infection that causes a polio-like disease in children. The research is expected to provide clues about how this virus attacks the body.
Jurado is the recipient of several major grants and fellowships, including the L'Oréal Women in Science Fellowship, the Charles H. Revson Senior Fellowship in Biomedical Science, and a Burroughs Wellcome Fund Postdoctoral Fellowship. She was named a 2018 "Wunderkind” by the life sciences publication STAT. She received her PhD in virology from Harvard University and served as a postdoctoral fellow at Yale University.
Jurado grew up in a small town in New Mexico where her family engages in chile pepper farming and business. Guided by her own experiences as a first-generation doctoral student who did not meet a scientist until college, Jurado gives back to the community by mentoring students at Harvard and Yale and within underserved middle and high schools in the New Haven/Bridgeport area. She has also engaged in community outreach by educating communities there about the HPV vaccine. The Hartford Courant has named her a Hometown Hero for these activities.
The Presidential Professorships are five-year term chairs, awarded by University of Pennsylvania President Amy Gutmann to outstanding scholars, whose appointments to the standing faculty are approved by the Provost and who demonstrably contribute excellence and diversity to Penn’s inclusive community.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.